Somatic mitochondrial mutations in pilocytic astrocytoma
Maria Lueth1, Lena Wronski, Almut Giese
1Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Cancer Genetics and Cytogenetics
|June 2, 2009
Summary
Pediatric pilocytic astrocytomas (PA) frequently harbor mitochondrial DNA (mtDNA) mutations, particularly in protein-coding regions involved in cellular energy production. These findings highlight mtDNA mutations as a potential factor in PA tumor development.
Area of Science:
- Oncology
- Genetics
- Mitochondrial Biology
Background:
- Pilocytic astrocytomas (PA) are the most common pediatric brain tumors.
- Mitochondrial DNA (mtDNA) defects are increasingly linked to various cancers.
- The role of mtDNA mutations in PA pathogenesis remains largely unexplored.
Purpose of the Study:
- To investigate the presence and spectrum of somatic mitochondrial DNA (mtDNA) mutations in pediatric pilocytic astrocytomas (PA).
- To determine the frequency and location of these mutations within the mitochondrial genome.
Main Methods:
- Whole mitochondrial genome sequencing was performed on tumor tissue and blood samples from 19 PA patients.
- Somatic mutations were identified by comparing tumor and blood mtDNA sequences.
- Mutation analysis focused on protein-coding regions and pathways of oxidative phosphorylation.
Main Results:
- Somatic mtDNA mutations were detected in 84% (16 out of 19) of PA tissue samples.
- A total of 34 distinct somatic mtDNA mutations were identified.
- Half of these mutations (17) were located in genes critical for oxidative phosphorylation, including specific missense mutations in ATP synthase, cytochrome b, and cytochrome c oxidase subunit 1.
Conclusions:
- Mitochondrial DNA mutations are common in pilocytic astrocytomas.
- These mutations frequently occur in protein-coding regions essential for cellular respiration.
- PA exhibits a higher prevalence of mitochondrial mutations compared to other studied neuroectodermal tumors, warranting further investigation into their prognostic significance.
Related Concept Videos
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...